Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 751 AL 765

Does vascular pathology contribute to Alzheimer changes?

Kalaria RN, Akinyemi R, Ihara M.

J Neurol Sci. 2012 Nov 15;322(1-2):141-7. doi: 10.1016/j.jns.2012.07.032. Epub 2012 Aug 11.

Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?

Richard F, Pasquier F.

J Alzheimers Dis. 2012;32(3):765-72. doi: 10.3233/JAD-2012-121012.

Cerebrovascular assessment for the risk prediction of Alzheimer's disease

Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F.

J Alzheimers Dis. 2012;32(3):689-98. doi: 10.3233/JAD-2012-121240.

Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease

Daulatzai MA.

Neurochem Res. 2012 Dec;37(12):2627-58. doi: 10.1007/s11064-012-0854-6. Epub 2012 Aug 12.

Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease

Chhatwal JP, Sperling RA.

J Alzheimers Dis. 2012;31 Suppl 3(0 3):S155-67. doi: 10.3233/JAD-2012-120730.

Epidemiology of Alzheimer disease

Mayeux R, Stern Y.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006239. doi: 10.1101/cshperspect.a006239.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56.

Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity

Misiak B, Leszek J, Kiejna A.

Brain Res Bull. 2012 Nov 1;89(3-4):144-9. doi: 10.1016/j.brainresbull.2012.08.003. Epub 2012 Aug 18.

Primary progressive aphasia and Alzheimer's disease: brief history, recent evidence

Kirshner HS.

Curr Neurol Neurosci Rep. 2012 Dec;12(6):709-14. doi: 10.1007/s11910-012-0307-2.

Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study

Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC, Weamer EA, DeMichele-Sweet MA, Kuller LH.

Am J Psychiatry. 2012 Sep;169(9):954-62. doi: 10.1176/appi.ajp.2012.11121815.

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S; GuidAge Study Group.

Lancet Neurol. 2012 Oct;11(10):851-9. doi: 10.1016/S1474-4422(12)70206-5. Epub 2012 Sep 6.

Vascular burden and Alzheimer disease pathologic progression

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Sep 25;79(13):1349-55. doi: 10.1212/WNL.0b013e31826c1b9d. Epub 2012 Sep 12.

From Alzheimer's disease retrogenesis: a new care strategy for patients with advanced dementia

Venturelli M, Magalini A, Scarsini R, Schena F.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):483-9. doi: 10.1177/1533317512459794. Epub 2012 Sep 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias